The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
The introduction of adrenocortical extract in 1930 improved the life expectancy of hyhpoadrenal patients, with further increases seen after the introduction of cortisone acetate from 1948. Most patients are now treated with synthetic hydrocortisone, and incremental advances have been made with optim...
Main Authors: | Sirazum Choudhury, Tricia Tan, Katharine Lazarus, Karim Meeran |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2021-03-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/10/2/EC-20-0473.xml |
Similar Items
-
Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
by: David J F Smith, et al.
Published: (2017-10-01) -
Improved salivary cortisol rhythm with dual-release hydrocortisone
by: Filippo Ceccato, et al.
Published: (2018-10-01) -
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
by: V Guarnotta, et al.
Published: (2019-06-01) -
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
by: Marcus Quinkler, et al.
Published: (2016-12-01) -
October 2013 critical care case of the month: slow to respond
by: Mohning M
Published: (2013-10-01)